Triple negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR) as well as the gene expression of human epidermal growth factor receptor 2 (HER2) (Denkert et al., 2016). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.